科研之友
微信
新浪微博
Facebook
分享链接
摘要
There has been a steady retreat by the private sector away from developing medications for mental disorders. This retreat comes just as research is identifying new molecular targets, new clinical targets, and new uses of current treatments that may serve as the basis for the next generation of treatments for mental disorders.
- 出版日期2012-10-10
